In the present study was made to develop a suitable matrix type transdermal patch of Candesartan Cilexetil, using blends of two different types of polymeric combinations viz. HPMC K100 and Eudragit RL100 prepared formulations were subjected to various physiochemical evaluation tests like moisture content loss, moisture absorption, flatness to study the stability of the formulations, in vitro dissolution was performed to determine the amount of Candesartan present in the patches. Drug excipient interaction studies were carried out using Fourier transform infrared (FTIR) spectroscopy technique. The in vitro release of the drug from the formulations was studied using commercial semi permeable membrane. All the formulations were found to be suitable for formulating in terms of physiochemical characteristics and there was no notification in significant interaction between the drug and polymer used. In vitro dissolution data showed that formulation of F11 showed faster release of drug than the F14 formulations during dissolution studies. Skin irritation studies revealed that the batch containing HPMCK100-Eudragit RL100 has no erythema and edema. Based on the observation, we can reveal that HPMCK100-eudragit RL100 polymers are better suited for the development of Candesartan cilexetil transdermal patches.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.